Abrdn Life Sciences Investors (HQL)

NYSE: HQL · Real-Time Price · USD

18.44

-0.30 (-1.60%)

Oct 30, 2026, 4:00 PM EDT - Market closed

HQL Financials Overview

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Revenue	1.11	1.94	3.98	3.5	3.02	2.29
Revenue Growth	-42.75%	-51.30%	13.75%	15.89%	32.05%	-32.59%
Gross Profit	1.11	1.94	3.98	3.5	3.02	2.29
Operating Income	-4.75	-3.37	-1.92	-2.18	-2.99	-4.14
Net Income	198.17	85.59	85.3	22.35	-104.6	64.53
Earnings Per Share	6.52	2.89	3.04	0.83	-4.07	2.62
EPS Growth	125.36%	-4.86%	264.33%	-	-	-49.23%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Investments	-	0.08	0	0	0	0
Total Debt	-	-	-	-	11.09	10.04
Net Cash (Debt)	-	0.08	0	0	-11.09	-10.04
Net Cash Growth	-	7553700.00%	-99.79%	-	-	-
Net Cash Per Share	-	0.00	-	0.00	-0.43	-0.41

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Operating Cash Flow	39.81	31.71	-	-	-	-
Free Cash Flow	39.81	31.71	-	-	-	-
Free Cash Flow Growth	25.56%	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-428.36%	-174.11%	-48.25%	-62.18%	-99.05%	-181.04%
Pretax Margin	17856.98%	4415.74%	2143.13%	638.86%	-3464.88%	2822.50%
Profit Margin	17856.98%	4415.74%	2143.13%	638.86%	-3464.88%	2822.50%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Dividend Per Share	1.820	1.820	1.660	1.280	1.470	1.670
Dividend Per Share Growth	23.08%	9.64%	29.69%	-12.93%	-11.98%	13.61%
Dividend Yield	9.87%	12.03%	11.29%	10.49%	10.99%	8.16%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
PE Ratio	2.83	5.23	4.84	14.62	-	7.83
PS Ratio	505.27	231.02	103.63	93.42	113.77	220.89